Positions

Selected Publications

Academic Article

Year Title Altmetric
2016 The effects of differences in pspA alleles and capsular types on the resistance of Streptococcus pneumoniae to killing by apolactoferrin.Microbial Pathogenesis.  99:209-219. 2016
2016 Monoclonal Antibodies to Shigella Lipopolysaccharide Are Useful for Vaccine Production.Clinical and Diagnostic Laboratory Immunology.  23:681-688. 2016
2016 Colonization potential to reconstitute a microbe community in patients detected early after fecal microbe transplant for recurrent C. difficile.BMC Microbiology.  16:5. 2016
2015 Discovery and Characterization of Human-Urine Utilization by Asymptomatic-Bacteriuria-Causing Streptococcus agalactiae.Infection and Immunity.  84:307-319. 2015
2015 Loss of Vancomycin-Resistant Enterococcus Fecal Dominance in an Organ Transplant Patient With Clostridium difficile Colitis After Fecal Microbiota Transplant.Open Forum Infectious Diseases.  2:ofv078. 2015
2014 Copper complexation screen reveals compounds with potent antibiotic properties against methicillin-resistant Staphylococcus aureus.Antimicrobial Agents and Chemotherapy.  58:3727-3736. 2014
2013 Asymptomatic bacteriuria: prevalence rates of causal microorganisms, etiology of infection in different patient populations, and recent advances in molecular detection.FEMS Microbiology Letters.  346:1-10. 2013
2013 Erratum: Diversity of group B streptococcus serotypes causing urinary tract infection in adults (Journal of Clinical Microbiology (2009) 47:7 (2055-2060))Journal of Clinical Microbiology.  51:2806. 2013
2012 Prognostic value of semi-quantitative bacteruria counts in the diagnosis of group B streptococcus urinary tract infection: a 4-year retrospective study in adult patients.BMC Infectious Diseases.  12:273. 2012
2012 Device for carrying blood samples at 37°C for cryoglobulin test.Clinical and Diagnostic Laboratory Immunology.  19:1555-1556. 2012
2012 Genome-wide mapping of cystitis due to Streptococcus agalactiae and Escherichia coli in mice identifies a unique bladder transcriptome that signifies pathogen-specific antimicrobial defense against urinary tract infection.Infection and Immunity.  80:3145-3160. 2012
2012 Group B streptococcus cystitis presenting in a diabetic patient with a massive abdominopelvic abscess: a case report.Journal of Medical Case Reports.  6:237. 2012
2011 Development of an automated and multiplexed serotyping assay for Streptococcus pneumoniae.Clinical and Diagnostic Laboratory Immunology.  18:1900-1907. 2011
2011 Serine protease PrtA from Streptococcus pneumoniae plays a role in the killing of S. pneumoniae by apolactoferrin.Infection and Immunity.  79:2440-2450. 2011
2010 Hit-and-run stimulation: a novel concept to reactivate latent HIV-1 infection without cytokine gene induction.Journal of Virology.  84:8712-8720. 2010
2010 Group B Streptococcus (GBS) urinary tract infection involves binding of GBS to bladder uroepithelium and potent but GBS-specific induction of interleukin 1alpha.Journal of Infectious Diseases.  201:866-870. 2010
2009 Diversity of group B streptococcus serotypes causing urinary tract infection in adults.Journal of Clinical Microbiology.  47:2055-2060. 2009
2008 PIR-B-deficient mice are susceptible to Salmonella infection.Journal of Immunology.  181:4229-4239. 2008
2006 Risk of infection and tracking of work-related infectious diseases in the funeral industry.American Journal of Infection Control.  34:655-660. 2006
2006 Case report: Severe hemolytic disease of the newborn in a group B African-American infant delivered by a group O motherAnnals of Clinical and Laboratory Science.  36:205-207. 2006
2006 Validation of a multiplex pneumococcal serotyping assay with clinical samples.Journal of Clinical Microbiology.  44:383-388. 2006
2005 Antibodies to the pneumococcal surface protein A, PspA, can be produced in splenectomized and can protect splenectomized mice from infection with Streptococcus pneumoniae.Vaccine.  23:4257-4262. 2005
2005 Relative fitness of fluoroquinolone-resistant Streptococcus pneumoniae.Emerging Infectious Diseases.  11:814-820. 2005
2005 Long-term molecular analysis of tuberculosis strains in alabama, a state characterized by a largely indigenous, low-risk population.Journal of Clinical Microbiology.  43:870-878. 2005
2005 Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activityJournal of Clinical Investigation.  115:66-75. 2005
2005 Rapid multiplex assay for serotyping pneumococci with monoclonal and polyclonal antibodies.Journal of Clinical Microbiology.  43:156-162. 2005
2004 Erratum: PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin (Infection and Immunity (2004) 72, 9 (5031-5040))Infection and Immunity.  72:7379. 2004
2004 Lipoprotein PsaA in virulence of Streptococcus pneumoniae: surface accessibility and role in protection from superoxide.Infection and Immunity.  72:5858-5867. 2004
2004 PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin [corrected].Infection and Immunity.  72:5031-5040. 2004
2003 Dissemination of macrolide-resistant Streptococcus pneumoniae isolates containing both erm(B) and mef(A) in South Korea.Journal of Clinical Microbiology.  41:5787-5791. 2003
2003 Evaluation of an extensive tuberculosis contact investigation in an urban community and jail.International Journal of Tuberculosis and Lung Disease.  7:S417-S423. 2003
2003 The rapid development of fluoroquinolone resistance in M. tuberculosis.New England Journal of Medicine.  349:1977-1978. 2003
2003 Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae.Journal of Infectious Diseases.  188:339-348. 2003
2003 Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides.Clinical and Diagnostic Laboratory Immunology.  10:514-519. 2003
2003 Genetic relatedness of levofloxacin-nonsusceptible Streptococcus pneumoniae isolates from North America.Journal of Clinical Microbiology.  41:2458-2464. 2003
2003 Vancomycin-resistant enterococci: 15 years and counting.Journal of Hospital Infection.  53:159-171. 2003
2003 Association between antecedent intravenous antimicrobial exposure and isolation of vancomycin-resistant enterococci.Microbial Drug Resistance.  9 Suppl 1:S69-S77. 2003
2003 Ligase chain reaction.Methods in Molecular Biology.  226:135-150. 2003
2002 Evidence for Epstein-Barr virus autoantibodies against human brain in demyelinating encephalitis.Neuropathology and Applied Neurobiology.  28:498-501. 2002
2002 Cross-jurisdictional transmission of Mycobacterium tuberculosis in Maryland and Washington, D C, 1996-2000, linked to the homeless.Emerging Infectious Diseases.  8:1249-1251. 2002
2002 Molecular differentiation of Mycobacterium tuberculosis strains without IS6110 insertions.Emerging Infectious Diseases.  8:1310-1313. 2002
2002 Molecular epidemiology of tuberculosis in a low- to moderate-incidence state: are contact investigations enough?Emerging Infectious Diseases.  8:1271-1279. 2002
2002 Molecular epidemiology of tuberculosis in a sentinel surveillance population.Emerging Infectious Diseases.  8:1197-1209. 2002
2002 Molecular typing of Mycobacterium tuberculosis strains with a common two-band IS6110 pattern.Emerging Infectious Diseases.  8:1303-1305. 2002
2002 Expression, autoregulation, and DNA binding properties of the Mycobacterium tuberculosis TrcR response regulator.Journal of Bacteriology.  184:2192-2203. 2002
2001 In vitro activity of ABT-773, telithromycin and eight other antimicrobials against erythromycin-resistant Streptococcus pneumoniae respiratory isolates of children.International Journal of Antimicrobial Agents.  18:531-535. 2001
2001 Value of Mycobacterium tuberculosis fingerprinting as a tool in a rural state surveillance program.Chest.  120:1877-1882. 2001
2001 Clinical isolates of Streptococcus pneumoniae resistant to levofloxacin contain mutations in both gyrA and parC genes.International Journal of Antimicrobial Agents.  18:373-378. 2001
2001 Epidemiologic usefulness of spoligotyping for secondary typing of Mycobacterium tuberculosis isolates with low copy numbers of IS6110.Journal of Clinical Microbiology.  39:3709-3711. 2001
2001 Identification of a contaminating Mycobacterium tuberculosis strain with a transposition of an IS6110 insertion element resulting in an altered spoligotype.Journal of Clinical Microbiology.  39:1092-1096. 2001
2001 Direct identification of Mycobacterium avium complex and Mycobacterium gordonae from MB/BacT bottles using AccuProbe.Journal of Clinical Microbiology.  39:570-573. 2001
2000 Human C-reactive protein is protective against fatal Salmonella enterica serovar typhimurium infection in transgenic mice.Infection and Immunity.  68:5652-5656. 2000
2000 The MB/BacT is a sensitive method of isolating Mycobacterium tuberculosis from clinical specimens in a laboratory with a low rate of isolation.Journal of Clinical Microbiology.  38:3133-3134. 2000
2000 Use of clindamycin disks To detect macrolide resistance mediated by ermB and mefE in Streptococcus pneumoniae isolates from adults and children.Journal of Clinical Microbiology.  38:1731-1734. 2000
1999 Comparison of direct inoculation and Copan transport systems for isolation of Neisseria gonorrhoeae from endocervical specimens.Journal of Clinical Microbiology.  37:3583-3585. 1999
1999 Spot sputum screening: evaluation of an intervention in two homeless shelters.International Journal of Tuberculosis and Lung Disease.  3:613-619. 1999
1999 In vitro evidence of two-component system phosphorylation between the Mycobacterium tuberculosis TrcR/TrcS proteins.Microbial Pathogenesis.  26:195-206. 1999
1998 Comparison of the MB/BacT system with a revised antibiotic supplement kit to the BACTEC 460 system for detection of mycobacteria in clinical specimens.Journal of Clinical Microbiology.  36:3234-3238. 1998
1998 Restriction fragment length polymorphism screening of Mycobacterium tuberculosis isolates: population surveillance for targeting disease transmission in a community.International Journal of Tuberculosis and Lung Disease.  2:655-662. 1998
1997 Avirulence of LT2 strains of Salmonella typhimurium results from a defective rpoS gene.Infection and Immunity.  65:2451-2453. 1997
1997 Bacterial phenotypes mediated by mviA and their relationship to the mouse virulence of Salmonella typhimurium.Microbial Pathogenesis.  22:353-362. 1997
1996 Transmission of mycobacterium tuberculosis to recipients of single lung transplants from the same donorPneumologie.  50:733. 1996
1996 Immunoprotection by monoclonal antibodies to the porins and lipopolysaccharide of Salmonella typhimurium.Microbial Pathogenesis.  21:249-263. 1996
1996 The predicted amino acid sequence of the Salmonella typhimurium virulence gene mviAA(+) strongly indicates that MviA is a regulator protein of a previously unknown S. typhimurium response regulator family.Infection and Immunity.  64:2365-2367. 1996
1996 Acid shock induction of RpoS is mediated by the mouse virulence gene mviA of Salmonella typhimurium.Journal of Bacteriology.  178:2572-2579. 1996
1996 Transmission of Mycobacterium tuberculosis to recipients of single lung transplants from the same donor.American Journal of Respiratory and Critical Care Medicine.  153:1166-1168. 1996
1995 Laboratory contamination of Mycobacterium tuberculosis cultures.American Journal of Respiratory and Critical Care Medicine.  152:1702-1704. 1995
1994 Mouse virulence gene A (mviA+) is a pleiotropic regulator of gene expression in Salmonella typhimurium.Annals of the New York Academy of Sciences.  730:295-296. 1994
1994 The intracellular nature of Salmonella infection during the early stages of mouse typhoid.Immunology series.  60:303-312. 1994
1993 In vivo administration of the anticancer agent bryostatin 1 activates platelets and neutrophils and modulates protein kinase C activity.Cancer Research.  53:2810-2815. 1993
1992 A 'safe-site' for Salmonella typhimurium is within splenic polymorphonuclear cells.Microbial Pathogenesis.  13:181-190. 1992
1992 Detection of DNA in Southern blots by chemiluminescence is a sensitive and rapid technique.BioTechniques.  12:836-838. 1992
1992 In vivo administration of bryostatin 1, a protein kinase C activator, decreases murine resistance to Salmonella typhimurium.Cancer Research.  52:2143-2147. 1992
1991 The Salmonella typhimurium locus mviA regulates virulence in Itys but not Ityr mice: functional mviA results in avirulence; mutant (nonfunctional) mviA results in virulence.Journal of Experimental Medicine.  174:1073-1083. 1991
1991 A hemA mutation renders Salmonella typhimurium avirulent in mice, yet capable of eliciting protection against intravenous infection with S. typhimurium.Microbial Pathogenesis.  11:289-295. 1991
1991 A 'safe-site' for Salmonella typhimurium is within splenic cells during the early phase of infection in mice.Microbial Pathogenesis.  10:297-310. 1991
1991 Mouse hepatitis virus strain UAB infection enhances resistance to Salmonella typhimurium in mice by inducing suppression of bacterial growth.Infection and Immunity.  59:852-856. 1991
1990 The primary effect of the Ity locus is on the rate of growth of Salmonella typhimurium that are relatively protected from killing.Journal of Immunology.  144:3143-3151. 1990
1989 Antipneumococcal effects of C-reactive protein and monoclonal antibodies to pneumococcal cell wall and capsular antigens.Infection and Immunity.  57:1457-1464. 1989
1989 Modulation of resistance to Salmonella typhimurium infection in mice by mouse hepatitis virus (MHV).Microbial Pathogenesis.  6:81-91. 1989
1986 Effects of in vitro growth phase on the pathogenesis of Salmonella typhimurium in mice.Journal of general microbiology.  132:1283-1295. 1986
1986 Genetic mapping of novel virulence determinants of Salmonella typhimurium to the region between trpD and supD.Microbial Pathogenesis.  1:115-124. 1986
1986 Salmonella typhimurium virulence genes necessary to exploit the Itys/s genotype of the mouse.Infection and Immunity.  51:872-878. 1986
1986 Independence of macrophage activation and expression of the alleles of the Ity (immunity to typhimurium) locus.Microbial Pathogenesis.  1:33-41. 1986
1986 Genetic approaches to the study of disease resistance: with special emphasis on the use of recombinant inbred mice.Current Topics in Microbiology and Immunology.  124:21-35. 1986
1986 Genetic control of the susceptibility to pneumococcal infection.Current Topics in Microbiology and Immunology.  124:103-120. 1986
1985 Induction of germ-line anti-alpha 1-3 dextran antibody responses in mice by members of the Enterobacteriaceae family.Journal of Immunology.  135:3468-3472. 1985
1985 The ability of Salmonella typhimurium to produce the siderophore enterobactin is not a virulence factor in mouse typhoid.Infection and Immunity.  50:392-397. 1985
1984 Blood clearance by anti-phosphocholine antibodies as a mechanism of protection in experimental pneumococcal bacteremia.Journal of Immunology.  133:3308-3312. 1984
1981 A genetic locus responsible for salmonella susceptibility in BSVS mice is not responsible for the limited T-dependent immune responsiveness of BSVS mice.Journal of Immunology.  127:906-911. 1981

Research Overview

  • Clinical parasitology in Alabama, investigating zoonotic parasites that can infect humans. Diagnostic Mycobacteriology, mainly decreasing time to diagnosis of Mycobacterial infections
  • Education And Training

  • Doctor of Philosophy in Microbiology, University of Alabama at Birmingham
  • Full Name

  • William Benjamin
  • Blazerid

  • bbenjami